While current therapy of diabetes has targeted glucose control, treatment of diabetic complications, for example, neuropathy, aside from striving for good metabolic control has been only symptomatic
This medicine is safe in patients of liver and kidney disease
Levocarnitine is an amino-acid derivative essential for mitochondrial fatty-acid transport, and this injectable formulation is used to treat or prevent clinically significant carnitine deficiency in conditions such as primary systemic carnitine deficiency, certain inborn errors of metabolism, and end-stage renal disease on dialysis
It supports red blood cell formation, neurological health, and DNA synthesis
social support
Note, the similar beneficial results of BPC 157 therapy obtained after different application routes are consistent with the high applicability of the agent, whatever route of the application [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] overwhelms limited applicability and activity to prophylactic application only of standard cytoprotective agents [41,42,43,44,45,46,47,48,49]
